PtBio Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
15
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$1.76M
- Investors
-
12
PtBio General Information
Description
Developer of a bioinformatics platform designed to manipulate and study deoxyribonucleic acid (DNA) sequences. The company's tool offers alignment, variant calling, and functional annotation to identify genes involved in target functions through extensive genome information and conducts mutational analysis to verify and confirm desired genetic mutations, enabling biotechnology and pharmaceutical companies to design and test new products, improve inherited traits, and accelerate research and development timelines.
Contact Information
Website
www.pt-bio.comCorporate Office
- 3-10-23 Kagamiyama
- Higashi-Hiroshima, Hiroshima 739-0046
- Japan
Corporate Office
- 3-10-23 Kagamiyama
- Higashi-Hiroshima, Hiroshima 739-0046
- Japan
PtBio Timeline
PtBio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Later Stage VC | 08-Sep-2025 | $1.76M | Completed | Generating Revenue | ||
| 8. Early Stage VC (Series A) | 25-Oct-2023 | Completed | Generating Revenue | |||
| 7. Accelerator/Incubator | 12-Oct-2023 | Completed | Generating Revenue | |||
| 6. Accelerator/Incubator | 13-Sep-2023 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 01-Jan-2022 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series B) | 10-Sep-2021 | Completed | Startup | |||
| 3. Accelerator/Incubator | Completed | Startup | ||||
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. University Spin-Out | 30-Aug-2019 | Completed | Startup |
PtBio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Class F Preferred | ||||||||
| Class E Preferred | ||||||||
| Class D Preferred | ||||||||
| Class C Preferred | ||||||||
| Class B Preferred | 3,200,000 | $0.000017 | $0.59 | $0.59 | 1x | $0.59 | 14.57% | |
| Class A Preferred | 440,000 | $0.000017 | $0.3 | $0.3 | 1x | $0.3 | 2% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
PtBio Patents
PtBio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2025017235-A | Method for estimating mutation introduction efficiency by genome edit tool | Active | 24-Jul-2023 | ||
| JP-7923550-B2 | Method for estimating the efficiency of mutation introduction using genome editing tools | Active | 24-Jul-2023 | ||
| WO-2024070589-A1 | Off-target risk analysis method, off-target risk analysis system, program and recording medium | Inactive | 30-Sep-2022 | ||
| JP-7878661-B2 | Off-target risk analysis method, off-target risk analysis system, program, recording medium | Active | 30-Sep-2022 |
PtBio Signals
PtBio Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Chugin Capital Partner | Venture Capital | Minority | ||
| Kewpie | Corporation | Minority | ||
| Tomita Pharmaceutical (Multi-line Chemicals) | Corporation | Minority | ||
| Kobe University Capital | Venture Capital | Minority | ||
| Tsuneishi Capital Partners | Corporate Venture Capital | Minority |
PtBio FAQs
-
When was PtBio founded?
PtBio was founded in 2019.
-
Where is PtBio headquartered?
PtBio is headquartered in Higashi-Hiroshima, Japan.
-
What is the size of PtBio?
PtBio has 15 total employees.
-
What industry is PtBio in?
PtBio’s primary industry is Biotechnology.
-
Is PtBio a private or public company?
PtBio is a Private company.
-
What is the current valuation of PtBio?
The current valuation of PtBio is .
-
What is PtBio’s current revenue?
The current revenue for PtBio is .
-
How much funding has PtBio raised over time?
PtBio has raised $5.82M.
-
Who are PtBio’s investors?
Chugin Capital Partner, Kewpie, Tomita Pharmaceutical (Multi-line Chemicals), Kobe University Capital, and Tsuneishi Capital Partners are 5 of 12 investors who have invested in PtBio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process